Please use this identifier to cite or link to this item:
|Title: ||Antiviral applications of RNAi for coronavirus|
|Authors: ||Chang-Jer Wu;Yi-Lin Chan|
|Contributors: ||NTOU:Department of Food Science|
|Keywords: ||antiviral agent;coronavirus;severe acute respiratory syndrome;short interfering RNAs|
|Issue Date: ||2011-10-21T02:23:44Z
|Publisher: ||Expert Opinion on Investigational Drugs|
|Abstract: ||Abstract:Until the appearance of severe acute respiratory syndrome (SARS), caused by the SARS coronavirus (SARS-CoV) in early 2003, coronavirus infection was not considered to be serious enough to be controlled by either vaccination or specific antiviral therapy. It is now believed that the availability of antiviral drugs effective against SARS-CoV will be crucial for the control of future SARS outbreaks. Recently, RNA interference has been successfully used as a more specific and efficient method for gene silencing. RNA interference induced by small interfering RNA can inhibit the expression of viral antigens and so provides a new approach to the therapy of pathogenic viruses. This review provides an overview of current information on coronavirus and the application of small interfering RNA in viral therapeutics, with particular reference to SARS-CoV.|
|Relation: ||15(2), pp.89-97|
|Appears in Collections:||[食品科學系] 期刊論文|
Files in This Item:
There are no files associated with this item.
All items in NTOUR are protected by copyright, with all rights reserved.